RingCentral calls for lower 2024 sales than Wall Street expects, and the stock falls
By Claudia Assis
RingCentral's fourth quarter comes in line
RingCentral Inc. shares fell more than 6% in the extended session Tuesday after the cloud-based communications company reported fourth-quarter earnings largely in line with Wall Street expectations, but its sales guidance for the year and for the current quarter fell short.
RingCentral (RNG) lost $47 million, or 50 cents a share, in the fourth quarter, compared with a loss of $284 million, or $2.97 a share, in the same period last year.
Adjusted for one-item items, the cloud-based communications company earned 86 cents a share.
Revenue rose to $571 million, from $525 million in the fourth quarter of 2022.
Analysts polled by FactSet expected RingCentral to report adjusted earnings of 82 cents on sales of $570.4 million.
The company guided for 2024 revenue between $2.370 billion and $2.395 billion, which would be growth of 8% to 9%. It called for adjusted EPS between $3.50 and $3.58.
For the first quarter, RingCentral guided for revenue between $575 million and $580 million, which would represent annual growth of 8% to 9%. EPS was seen between 79 cents and 80 cents.
The analysts surveyed by FactSet are looking for first-quarter revenue of $581 million, and adjusted EPS of 82 cents.
For the year, the expectation is for revenue of $2.4 billion, and adjusted EPS of $3.51.
Shares of RingCentral have lost about 17% in the past 12 months, contrasting with gains of 22% for the S&P 500 index SPX in the same period.
-Claudia Assis
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
02-20-24 1802ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks